PathologybioRxivPreprint
Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis.
Ben Higgins, Ioannis Simitsidellis, Xiaozhong Zheng…·Damian J. Mole
This study shows that blocking Kynurenine monooxygenase (KMO) reduces endometriosis-like lesions, alleviates pain, and improves behavior in a mouse model of endometriosis.
DOI 10.1101/2024.05.13.593856